Updated:
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001737523, and its reported industry...
Overview
BioNexus Gene Lab Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001737523, and its reported industry is Services-Medical Laboratories. In 10-K filed on 2026-04-14, it reported annual revenue of USD 7,424,911; net income of USD -2,984,607; total assets of USD 9,252,784 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- BioNexus Gene Lab Corp
- Former names in filing history
- BioNexus Gene Lab Coporation (2019-01-29 to 2020-05-08)
- Classification
- Public company
- Industry (SIC)
- 8071 — Services-Medical Laboratories
- Headquarters
- Kuala Lumpur, Malaysia
- Incorporated in
- WY
- Fiscal year end
- December 31
- Ticker
- Nasdaq: BGLC
- SEC CIK
- 0001737523
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $7.4M | -$3.0M | $9.3M | $2.5M | -$1.8M | |
| FY2024USD | $9.5M | -$1.6M | $10.4M | — | -$2.2M | |
| FY2023USD | $9.8M | -$2.6M | $11.4M | — | -$1.3M | |
| FY2022USD | $10.9M | -$355,966 | $8.7M | — | $544,028 |
FY2025. Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2024. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2023. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2022. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| DEF 14A | DEF 14A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research BioNexus Gene Lab Corp in Altss
Track this company’s investors, transactions and relationships in Altss.